Latest filingSep 09, 2026Most recent Form 4
ELAN
Elanco Animal Health Inc
NYSEHealthcarePharmaceutical Preparations
Insider activity for last month from 08/10 to 09/10. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$103M2 buys
Total selling$00 sells
Net open-market+$103M5 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period5transactions
- A · Grants / awards · dominant3 · 60%
- P · Open-market buys2 · 40%
Activity by reported role
A joint filing can contribute to multiple roles7transactions
- Director · dominant2 · 29%
- Chief executive officer1 · 14%
- EC1 · 14%
- GCS1 · 14%
- PRES1 · 14%
- SR1 · 14%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (3)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeO'Neill ShivCommon Stock · Direct
87,832Aug 18, 2026
Kurzius Lawrence ErikCommon Stock · Direct
188,647Aug 20, 2026
Simmons Jeffrey NDeferred Stock Units · Direct
25,245.5086Sep 04, 2026
Modi Rajeev A.Deferred Stock Units · Direct
9,830.5951Sep 04, 2026
VanHimbergen Robert MDeferred Stock Units · Direct
149.8658Sep 04, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 10 → Sep 10
LessMore
Top insiders
By absolute net value across the selected period- KE+$935.9k
- OS+$94.3k
- SN+$2.8k
- MA+$1.5k
- VM+$197
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
ELAN transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| ELAN | VanHimbergen Robert M | EC | grant | 8 | $19.7k | A | — | 0.0% | 09/09 | 09/04 |
| ELAN | Modi Rajeev A. | SR | grant | 60 | $147k | A | — | 0.0% | 09/09 | 09/04 |
| ELAN | Simmons Jeffrey N | PRESCEODIR | grant | 115 | $282k | A | — | 0.0% | 09/09 | 09/04 |
| ELAN | Kurzius Lawrence Erik | DIR | buy | 40.0k | $93.5M | P | +0.6% | 08/21 | 08/20 | |
| ELAN | O'Neill Shiv | GCS | buy | 3.99k | $9.42M | P | +1.1% | 08/18 | 08/18 |
Elanco Animal Health Inc Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Elanco Animal Health Inc?
VanHimbergen Robert M, Modi Rajeev A., Simmons Jeffrey N, Kurzius Lawrence Erik, O'Neill Shiv.
When was the latest reported open-market purchase?
Kurzius Lawrence Erik reported a buy on Aug 20, 2026 valued at $93.5M. Read the SEC filing.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
Net open-market buying in the selected period was $1,030,192.84. This describes filed transactions, not a bullish rating.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.